Cours OHR Pharmaceutical Inc Nasdaq
Actions
US67778H3093
Recherche biotechnologique et médicale
CA 2023 * | - | CA 2024 * | - | Capitalisation | 1,65 M 1,51 M |
---|---|---|---|---|---|
Résultat net 2023 * | -12 M -10,96 M | Résultat net 2024 * | - | VE / CA 2023 * | - |
Trésorerie nette 2023 * | - 0 | Trésorerie nette 2024 * | - 0 | VE / CA 2024 * | - |
PER 2023 * |
-0,06
x | PER 2024 * |
-
| Employés | - |
Rendement 2023 * |
-
| Rendement 2024 * |
-
| Flottant | 86,62% |
Dernier transcript sur OHR Pharmaceutical Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 10/01/22 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 01/11/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 12/07/19 |
Eric Richman
BRD | Director/Board Member | 63 | 12/07/19 |
Director/Board Member | 79 | 12/07/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,51% | 42,75 Md | |
+49,22% | 41,61 Md | |
+8,57% | 41,34 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md |